Literature DB >> 28936798

Conditioned Medium of Human Adipose Mesenchymal Stem Cells Increases Wound Closure and Protects Human Astrocytes Following Scratch Assay In Vitro.

Eliana Baez-Jurado1, Oscar Hidalgo-Lanussa1, Gina Guio-Vega1, Ghulam Md Ashraf2, Valentina Echeverria3,4, Gjumrakch Aliev5,6,7, George E Barreto8,9.   

Abstract

Astrocytes perform essential functions in the preservation of neural tissue. For this reason, these cells can respond with changes in gene expression, hypertrophy, and proliferation upon a traumatic brain injury event (TBI). Different therapeutic strategies may be focused on preserving astrocyte functions and favor a non-generalized and non-sustained protective response over time post-injury. A recent strategy has been the use of the conditioned medium of human adipose mesenchymal stem cells (CM-hMSCA) as a therapeutic strategy for the treatment of various neuropathologies. However, although there is a lot of information about its effect on neuronal protection, studies on astrocytes are scarce and its specific action in glial cells is not well explored. In the present study, the effects of CM-hMSCA on human astrocytes subjected to scratch assay were assessed. Our findings indicated that CM-hMSCA improved cell viability, reduced nuclear fragmentation, and preserved mitochondrial membrane potential. These effects were accompanied by morphological changes and an increased polarity index thus reflecting the ability of astrocytes to migrate to the wound stimulated by CM-hMSCA. In conclusion, CM-hMSCA may be considered as a promising therapeutic strategy for the protection of astrocyte function in brain pathologies.

Entities:  

Keywords:  Brain injury; Conditioned medium; Human astrocytes; Mesenchymal stem cells; Migration; Scratch

Mesh:

Substances:

Year:  2017        PMID: 28936798     DOI: 10.1007/s12035-017-0771-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  114 in total

Review 1.  Structural remodeling of astrocytes in the injured CNS.

Authors:  Daniel Sun; Tatjana C Jakobs
Journal:  Neuroscientist       Date:  2011-10-07       Impact factor: 7.519

Review 2.  Signaling pathways in reactive astrocytes, a genetic perspective.

Authors:  Wenfei Kang; Jean M Hébert
Journal:  Mol Neurobiol       Date:  2011-01-14       Impact factor: 5.590

3.  Essential protective roles of reactive astrocytes in traumatic brain injury.

Authors:  D J Myer; G G Gurkoff; S M Lee; D A Hovda; M V Sofroniew
Journal:  Brain       Date:  2006-07-05       Impact factor: 13.501

4.  Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay.

Authors:  Eliana Baez-Jurado; Gina Guio Vega; Gjumrakch Aliev; Vadim V Tarasov; Paula Esquinas; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.590

5.  Spinal cord injury-induced astrocyte migration and glial scar formation: effects of magnetic stimulation frequency.

Authors:  Zhe Li; Zheng-Yu Fang; Liang Xiong; Xiao-Lin Huang
Journal:  Indian J Biochem Biophys       Date:  2010-12       Impact factor: 1.918

6.  The epidemiology and impact of traumatic brain injury: a brief overview.

Authors:  Jean A Langlois; Wesley Rutland-Brown; Marlena M Wald
Journal:  J Head Trauma Rehabil       Date:  2006 Sep-Oct       Impact factor: 2.710

Review 7.  Cerebral structural and functional changes in type 1 diabetes.

Authors:  M C Stiles; E R Seaquist
Journal:  Minerva Med       Date:  2010-04       Impact factor: 4.806

8.  Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury.

Authors:  Zhilai Zhou; Yinhai Chen; Hui Zhang; Shaoxiong Min; Bo Yu; Bing He; Anmin Jin
Journal:  Cytotherapy       Date:  2013-02-01       Impact factor: 5.414

9.  Diverging volumetric trajectories following pediatric traumatic brain injury.

Authors:  Emily L Dennis; Joshua Faskowitz; Faisal Rashid; Talin Babikian; Richard Mink; Christopher Babbitt; Jeffrey Johnson; Christopher C Giza; Neda Jahanshad; Paul M Thompson; Robert F Asarnow
Journal:  Neuroimage Clin       Date:  2017-03-31       Impact factor: 4.881

10.  Identification of injury specific proteins in a cell culture model of traumatic brain injury.

Authors:  Camilla Lööv; Ganna Shevchenko; Aishwarya Geeyarpuram Nadadhur; Fredrik Clausen; Lars Hillered; Magnus Wetterhall; Anna Erlandsson
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more
  4 in total

1.  Current advances in in vitro models of central nervous system trauma.

Authors:  Anton Omelchenko; Nisha K Singh; Bonnie L Firestein
Journal:  Curr Opin Biomed Eng       Date:  2020-05-14

Review 2.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

Review 3.  Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer's Disease.

Authors:  Safikur Rahman; Ayyagari Archana; Arif Tasleem Jan; Rinki Minakshi
Journal:  Front Aging Neurosci       Date:  2018-02-06       Impact factor: 5.750

4.  The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.

Authors:  Yilong Shan; Sha Tan; Yinyao Lin; Siyuan Liao; Bingjun Zhang; Xiaodong Chen; Jihui Wang; Zhezhi Deng; Qin Zeng; Lei Zhang; Yuge Wang; Xueqiang Hu; Wei Qiu; Lisheng Peng; Zhengqi Lu
Journal:  J Neuroinflammation       Date:  2019-11-28       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.